Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Pulse Biosciences (PLSE) Other Operating Expenses (2021 - 2025)

Historic Other Operating Expenses for Pulse Biosciences (PLSE) over the last 3 years, with Q3 2025 value amounting to $279000.0.

  • Pulse Biosciences' Other Operating Expenses changed N/A to $279000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $279000.0, marking a year-over-year change of. This contributed to the annual value of $24.0 million for FY2022, which is 4332.8% up from last year.
  • According to the latest figures from Q3 2025, Pulse Biosciences' Other Operating Expenses is $279000.0.
  • Pulse Biosciences' 5-year Other Operating Expenses high stood at $10.4 million for Q3 2022, and its period low was $279000.0 during Q3 2025.
  • Its 3-year average for Other Operating Expenses is $4.6 million, with a median of $4.1 million in 2021.
  • The largest annual percentage gain for Pulse Biosciences' Other Operating Expenses in the last 5 years was 15223.92% (2022), contrasted with its biggest fall of 6111.43% (2022).
  • Pulse Biosciences' Other Operating Expenses (Quarter) stood at $5.3 million in 2021, then crashed by 61.11% to $2.1 million in 2022, then tumbled by 86.45% to $279000.0 in 2025.
  • Its Other Operating Expenses was $279000.0 in Q3 2025, compared to $2.1 million in Q4 2022 and $10.4 million in Q3 2022.